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Direct fluorogenic detection 
of palladium and platinum 
organometallic complexes 
with proteins and nucleic acids 
in polyacrylamide gels
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Allyl- and propargyl ethers of umbelliferone are sensitive probes for palladium and platinum, including 
anticancer compounds cisplatin, carboplatin and oxaliplatin, and effective for direct visualization of 
protein and DNA complexes with organometallic compounds in polyacrylamide gels allowing easy 
detection of interactions with analyzed protein or nucleic acid. Both probes can be used for fast 
evaluation of Pd/Pt binding to nanocarriers relevant in drug targeted therapy or specific clinically 
relevant target macromolecules.
Since the discovery of cisplatin as a potent anti-cancer compound, the general interest in therapeutic metal-
locomplexes dramatically increased. Identification of other platinum compounds with improved therapeutic 
properties further fueled the search for biologically active metallosubstances, which nowadays besides Pt and 
Pd, contain organocomplexes of gold,  ruthenium1, rhodium and  iridium2. Recent years have also seen a grow-
ing interest in palladium compounds that have therapeutic activity or whose catalytic activity can be used for 
prodrug activation in situ, in a therapeutic approach known as bioorthogonal  therapy3.
Current trends in cancer therapies have shifted from systemic drug administration to targeted cancer drug 
delivery utilizing various types of nanocarriers. This raises a practical problem of detecting whether the therapeu-
tic compound has been effectively encapsulated. Alternatively, metallodrugs might be directed against a specific 
protein (enzyme, regulatory molecule) and a facile technique is of utmost interest to detect such interactions. 
Methods used so far are mainly physio-chemical and require costly instrumentation available only to a limited 
number of laboratories. The techniques can also mostly detect only the presence of the metal ions but not their 
binding to a protein or nucleic acid. Binding of Pt and Pd complexes to DNA and proteins has been studied 
previously. In order to detect the formation of metal adducts with DNA spectrophotometric techniques detecting 
subtle changes in DNA absorption are  used4. Binding of Pt complexes to protein can be analyzed by electrospray 
ionization – mass spectroscopy (ESI–MS) and has been used to detect binding of Pt-benzimidazole complexes 
to  lysozyme4. This technique is precise but requires demanding samples preparation, special instrumentation, 
and is able to detect only stable coordination complexes between specific aminoacid and metal. In addition, the 
technique cannot be used to determine hydrophobic and other non-covalent or unstable coordination interac-
tions. Pt coordination complexes that are very stable could be determined by ESI–MS but Pd complexes where 
the ligand exchange rate is much faster might be missed.
We are interested in encapsulation of Pd and Pt complexes into protein nanocarriers, specifically ferritins 
for targeted drug  delivery5. Encapsulation of anticancer drugs, such as doxorubicin or ellipticine can be easily 
monitored due to inherent drugs fluorescence but there is no fast and simple technique to monitor metallocom-
pound encapsulation.
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That is why we have set to develop a technique that would permit direct visualization of such complexes with 
laboratory equipment commonly found in molecular biology labs using routine separation techniques such as 
polyacrylamide electrophoresis and detection system with standard laboratory transilluminator. The technique is 
not intended to analyze complex reaction mixes but to provide an insight whether a newly developed substances 
will interact with desired target macromolecule or evaluate whether the compound is effectively encapsulated 
in a given nanocarrier.
Majority of chemical sensors for the detection of noble metals utilizes their catalytic  properties6 with Pd 
sensors often based on allyl or propargyl carbamates, carbonates, or ethers of phenolic  fluorophores6–10. The 
fluorescent activation of the probes is based on the Tsuji-Trost allylic oxidative insertion  mechanism11. The  Pd0 
oxidatively inserts into the allylic C–O bond of the non-fluorescent allylic/propargylic ether and the complex 
reacts with a nucleophile consequently releasing a fluorescent alcohol and an allylated or propargylated nucleo-
phile. Many Pd complexes in a form of homogenous or heterogenus catalyst were used in cellular  context12–15 
to activate various fluorescent probes but the interaction with cellular proteins cannot be identified in this way.
Previously produced probes based on Pittsburgh  Green9,10,  dichlorofluorescein16,  resorufin8, 4-hydroxynaph-
thalimide17 are sensitive and allow facile detection of Pd in quantitative assays. However, they frequently retain a 
relatively high level of fluorescence under UV making them excellent probes for spectrophotometric assays and 
microscopy but less effective for the use with an UV transilluminator. The requirement for UV excitability and 
the lack of visible fluorescence of the probe ruled out most of the common fluorophores except coumarin-based 
compounds. Coumarins are blue fluorochromes used in probes design or as enzymatic substrates since  195518. 
Recently, a vinyl ether of umbelliferone (UF) was used as a reporter to monitor the traceless release of alcohols 
in cells after tetrazine mediated  uncaging19. Two probes based on 7-hydroxy-4-(trifluoromethyl)coumarin were 
developed by Ding et al. containing allyl carbonate and propargyl ether  moiety20. Some of these probes were used 
in vivo to detect Pd complexes in  cells21,22. However, the binding partner cannot be identified in a cellular context.
Here, we present new probes responsive to Pd, Pt and other transition metals, based on umbelliferone and 
demonstrate their use to detect protein and DNA complexes of Pd and Pt organometallic compounds as well as 
the metal complexes encapsulated into ferritin nanocarrier.
Results and discussion
Design, synthesis and evaluation of propargyloxy- and allyloxyumbelliferone (UF) probe. The 
probe design is based on UF, a coumarin analogue, with a hydroxyl group that can be easily modified by the 
reaction with allyl or propargyl bromide. The UF was also chosen due to its good solubility in water and suitable 
fluorescence. The fluorochrome can be easily excited at 365 nm, a wavelength provided by transilluminators used 
to detect ethidium bromide stained DNA in agarose gels resulting in bright blue fluorescence (the mechanism of 
probes activation is schematized in Fig. 1). The UF deprotonation is prerequisite for its fluorescence. Attachment 
of allyl- or propargyl groups to the UF hydroxyls effectively blocks the fluorescence upon excitation with UV at 
365 nm in alkaline medium (Fig. S3).
We have tested several reactions conditions based on previously published results. These included sodium 
borohydride  (NaBH4)16 and hydrazine  (NH2NH2)7 as the reducing agents in 20% acetonitrile (MeCN), dimethyl 
sulfoxide (DMSO), dimethylformamide (DMF), and in pure water. The use of triphenylphosphine (TPP)9 resulted 
in fluorescent artefacts and was therefore excluded from further experiments. Figure 2 demonstratesthe effects 
of various metal ions on efficiency of the probes activation .
The results demonstrate that both probes are efficiently activated by Pd, Pt, Ru, Rh, and Cu. In the case of 2, 
a very strong signal appears also in response to the presence of Au. Reactivity of both probes was outstanding 
in pure water in the presence of BH compared to mixed solvents and Hyd as a reducing agent. Quantitative 
data are summarized in Fig. S4. These results indicate that the sensitivity of other allyl/propargyl ether probes 
Figure 1.  Mechanism of activation and detection of allyl- (1) and propargylumbelliferone ether (2).
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synthesized by other groups could be further modified by changing the reaction conditions. These results can 
also aid in choosing appropriate deprotection conditions of organic molecules where allyl ether is used as a 
protecting group during chemical synthesis.
Since Pd is commonly used as a catalyst in the preparation of pharmaceutical substances and Pd contamina-
tion is of great health concerns, we were curious what would be the detection limit for Pd used for quantitative 
Pd determination.
The reaction was carried out in 20% ACN in order to improve the solubility of potential analytes.
We found that the detection limit for Pd(OAc)2 at an increased gain (60) is ~ 20 nM. The saturation is reached 
at Pd concentrations ~ 4 µM. Importantly, by a naked eye, Pd can be determined in a 96-well plate on a transil-
luminator in concentrations exceeding 150 nM (Fig S5).
Detection of organometallic compounds. Due to the strong response of both probes to inorganic 
metal ions, we were curious whether 1 and 2 can detect organometallic Pd and Pt compounds. The results show 
that all tested Pd complexes, and surprisingly also anticancer drugs cisplatin and carboplatin induce a strong 
increase in fluorescence (Fig. 3) of the assay carried out in water with BH. The inefficiency of Hyd to activate 
the probe in presence of Pt compounds could be explained by the inability of Hyd to reduce  Pt2+ into  Pt0. These 
results are exciting because only a few fluorescent sensors, such as rhodamine  triazole23, diethyldithiocarbamate-
rhodamine  B24, resorufin allyl  ether8, and Pittsburgh green allyl  ether10 are sensitive to Pt compounds. All pub-
lished probes respond differently to various Pt compounds; however, the sensitivity of only a few of them has 
been tested against anticancer complexes. Taken together, our results demonstrate that 1 and 2 are useful for the 
detection of some platinum anticancer compounds. The lack of activation of the probe with cisplatin, oxaliplatin, 
and carboplatin in presence of organic solvents can be possibly explained by the formation of stable complexes 
with DMSO or acetonitrile. Pohorilets et al.25 have analysed mechanism of Tsuji-Trost reaction in detail and has 
shown that excess of DMSO represses Pd mediated activation of allyl Pittsburg green.
Detection of Pd and Pt compounds in biological fluids. Clinical use of metallodrugs prompted us to 
test whether UF probes can be used for the detection of Pd and Pt compounds in biological fluids (serum, urine). 
We have reacted 1 and 2 with Pd or Pt compounds pre-incubated with urine or fetal bovine serum (Fig. 4). All 
Pd compounds can be easily detected, while Pt compounds do not activate any probe in the presence of serum or 
Figure 2.  Activation of 1 (A) and 2 (B) by various metals (10 μM) in different solvents and reducing agents 
in a 96-well plate placed under UV transilluminator. Pd = Pd(OAc)2, Pt = K2PtCl4, Rh = RhCl3, Ru = RuCl3, 
Au = AuCl3, Ir = K3IrCl6, Ni = Ni(OAc)2, Co = CoCl2, Cu = CuSO4, Fe = FeCl3, Mn = MnCl2, Hyd = hydrazine 
hydrate (10 mM), BH = sodium borohydride (5 mM), MeCN = acetonitrile (20%), DMSO = dimethylsulfoxide 
(20%), DMF = dimethylformamide (20%). The total reaction volume was 200 µL with 25 µM 1 or 2. The reaction 
time was 30 min. Red arrows highlight the differences between probes 1 and 2.
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urine, precluding the possibility to detect organoplatinum compounds in blood or urine of patients undergoing 
chemotherapy. Nevertheless, detection of drugs should not be affected by infusion solutions, and can be thus 
possibly used for sensing of cytostatic contaminations in the hospital environment.
Figure 3.  Activation of AllylUE (1) and PropUE (2) probes in presence of Pd or Pt 
complexes (10 μM) in various solvents and reducing agents in a 96-well plate placed on a UV 
transilluminator. Pd(OAc)2 = palladium(II) acetate,  Na2PdCl4 = sodium tetrachloropalladate(II), 
Pd(dba)2 = bis(dibenzylideneacetone)palladium(0), Pd(TFP)2Cl2 = bis(tri(2-furyl)phosphine)palladium(II) 
dichloride, AllylPd = Allylpalladium(II) chloride dimer, Pd(TPP)2Cl2 = bis(triphenylphosphine)palladium(II) 
dichloride, Pd(TPP)4 = tetrakis(triphenylphosphine)palladium(0), Pd Phthalocyanine = phthalocyanine 
palladium(II),  K2PtCl4 = potassium tetrachloroplatinate(II), Hyd = hydrazine hydrate (10 mM), BH = sodium 
borohydride (5 mM), MeCN (acetonitrile (20%), DMSO = dimethylsulfoxide (20%), DMF = dimethylformamide 
(20%). The total reaction volume was 200 µL with 25 µM AllylUE or PropUE. The reaction time is 30 min.
Figure 4.  Activation of AllylUE (1) and PropUE (2) probes by Pd catalysts and Pt drugs in fetal bovine serum 
(FBS) and urine. Pd catalysts and Pt drugs were mixed with 50 μL of FBS or urine in 96-well plate, incubated 
for 30 min at 25 °C, and 150 μL of reaction mixture with AllylUE or PropUE and BH in water was added with 
final concentrations of 5 μM catalyst, 25 μM probe, and 5 mM BH and incubated for 1 h at 23 °C. The plate 
was visualized on a UV transilluminator. PdAc = palladium(II) acetate, (TFP)2 = bis(tri(2-furyl)phosphine)
palladium(II) dichloride, (TPP)2 = bis(triphenylphosphine)palladium(II) dichloride, Phth = phthalocyanine 
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Direct visualisation of the interaction between Pd metallodrugs and proteins. The previous 
experiment confirmed that both probes are sensitive to Pd and Pt compounds. With the optimized reaction con-
ditions, we wanted to see whether Pd/Pt complexes with biomolecules can be visualized in native polyacrylamige 
gels (PAG). As a model protein, we have used recombinant ferritin originating from hyperthermophilic archaea 
Pyrococcus furiosus (Pfu)26, which is a promising drug nanocarrier. For comparison, we have used bovine serum 
albumin (BSA), which is a major plasma carrier protein important for binding and transport of many pharma-
cologically active  substances27.
Both proteins were incubated with a series of Pd compounds and separated on native PAG. The Pd complexes 
were detected by a direct application of  NaBH4 solution to the surface of gels previously soaked with the probe 
1 and placed on top of a common laboratory UV transilluminator (Fig. 5).In the same gel, the proteins can be 
detected by subsequent staining with Coomassie blue. The colocalisation of signals confirms the interaction 
between the studied organometallic compound and given macromolecule.
The images of PAGs shown in Fig. 5 revealed differences in interactions between Pd-complexes and either P. 
furiosus ferritin or BSA. The results show a very high affinity of Pfu ferritin for Pd-phthalocyanine, Pd(hfacac), 
Pd(TNFB)Cl2 while other catalysts bind moderately or not at all. On the other hand, BSA binds strongly inor-
ganic Pd (Pd(OAc)2 and  Na2PdCl4), Pd(hfacac), and Pd-spermine complex while other catalysts interact with 
BSA only moderately. The results demonstrate that our probes enable facile and sensitive detection of binding 
of Pd complexes to proteins and show clear distinctions in complex formation between various proteins with 
evaluated Pd compounds. It is worth to mention that the signal development might be accompanied by forma-
tion of  H2 bubbles underneath the gel and in order to acquire good images these bubbles should be pushed away 
by rolling a pipette over the gel.
Direct visualization of interactions between Pd metallodrugs and nucleic acids. Since some 
clinically used metallocomplexes are specifically designed to interact with cellular DNA we have tested whether 
we can use the established technique to detect the interaction of Pd complexes with DNA, specifically double-
stranded (dsDNA) and single-stranded DNA (ssDNA). For comparison, we utilized DNA oligonucleotide Ag45 
forming G-quadruplexes tertiary structure (qDNA)28. G-qadruplexes are structural motives present in telomeric 
regions of chromosomes that became target of new anticancer interventions. The Pd complexes were detected 
with probe 1 and DNA in the same gel was detected by subsequent staining with ethidium bromide (dsDNA) 
or crystal violet (ssDNA, qDNA) (Fig. 6). The results confirm an effective binding of some Pd complexes to 
DNA, though we have seen no substantial difference between affinities to various structural types. Inorganic 
salts, allylPd, and Pd(TNFB)Cl2 bind very poorly to any DNA. Pd(hfacac) interacts with dsDNA and ssDNA 
but the binding to qDNA is compromised. Noteworthy,  Pd0(Phen)2, which did not interact with PfuFt or BSA 
has a strong affinity for all types of DNA. We have also tested whether complexes of Pt and Ru with DNA can 
be detected by the proposed technique (Fig. S6). Regretably, we have not seen UPE activation by any tested 
comlex. We assume that very high concentration of acrylamide (16%) used to separate the small oligonucleotide 
fragments might be responsible because the Pt complexes with proteins separated in 5% acrylamide gels can be 
Figure 5.  Activation of AllylUE (1) in native PAG by Pd complexes with Pfu ferritin (a, b) and BSA (c, d). 
The complex was formed by incubation of 20 µg of protein with 100 µM catalyst for 12 h. The complexes were 
resolved in 5% native PAG in Tris–glycine buffer. The Pd catalyst was visualised with AllylUE (left) and the 
same gel was stained for detection of protein with Coomassie blue (right). The used catalysts were: 1—None, 
2—Pd(OAc)2, 3—Na2PdCl4, 4—Pd(TFP)2Cl2, 5—Pd(TPP)2Cl2, 6—Pd Phthalocyanine, 7—Pd-BBDPPE, 8—
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detected without problems. Neither borate present in the DNA separation gel nor DNA itself interfere with the 
reaction (data not shown).
The technique of detecting palladium, and possibly adapted for other metals, in complexes with nucleic 
acids can find its use also in synthetic biology, specifically in design of new artificial metal base pairs. In a 
metal-mediated base pair, the hydrogen bonds of a canonical base pair are formally replaced by coordinate 
bonds to one or more metal ions located in the interior of the  duplex29. The promissing strategy is the replace-
ment of nucleotides with imidazole derivatives, such as 1-(2-deoxy-β-D-ribofuranosyl) imidazole-4-carboxylate 
nucleoside triphosphate (dImCTP)30. The presence of silver ions supports the unusual coordination pattern. 
Such synthetic nucleic acids can find its use in nanotechnology, supramolecular coordination chemistry etc. 
Of interest might be a design of new atomic metal arrays assembled in artificial DNA. This concept has been 
described for copper coordination array coordinated in hydroxypyridone  nucleobases31. Replacement of copper 
with palladium or other metals might lead to the development of effective catalyst with potential applications 
in bioorthogonal chemistry.
Direct visualization of interactions between anticancer platinum compounds and ferritin 
nanocarriers. Unfortunately, we found that Pt complexes with proteins or DNA cannot be detected in PAG. 
In order to address this issue, we have tested individual components of PAG for the reaction inhibition and found 
that the inhibitory compound is acrylamide itself. We hypothesized that acrylamide that remains incompletely 
polymerized in the gel, does interact with Pt and suppresses its catalytic activity. Moreover, we hypothesized that 
Figure 6.  Activation of AllylUE (1) (a, c, e) in PAG gels by Pd complexes with dsDNA (a, b), qDNA (c, d), 
and ssDNA (e, f). The gels after detection of AllylUE activation were stained with ethidium bromide (b) or 
crystal violet (d, f) to visualise the DNA. The complex was formed by incubation of 10 µM oligonucleotide with 
100 µM catalyst. The complexes were resolved in 16% PAG in Tris–Borate buffer. The used catalysts were: 1—
None, 2—Pd(OAc)2, 3—Na2PdCl4, 4—Pd(TFP)2Cl2, 5—Pd(TPP)2Cl2, 6—Pd Phthalocyanine, 7—Pd-BBDPPE, 
8—Pd(hfacac), 9—AllylPd, 10—Pd-Spermine, 11—Pd(bipy)Cl2, 12—PdPhen(OAc)2, 13—Pd(TNFB)Cl2, 14—
Pd2(dipic)2(TPP)2, 15  Pd0(Phen)2.
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supplementing the system with another metal ion that would compete with Pt for binding to acrylamide might 
liberate Pt and revive its catalytic activity and permit the probe activation.
In order to prove the hypothesis, we have mixed cisplatin, carboplatin, and oxaliplatin with acrylamide and 
other metal ions (that do not activate the probe itself) in 10 molar excess and carried out the deprotection assay. 
Surprisingly, we found that some catalytic activity is restored after addition of  Co2+ or  Ni2+, and to a lesser extent 
 Fe2+ (Fig. 7) for all tested cytostatics. The sensitivity of the probe to cisplatin is also partially restored by  Mn2+, 
and  In3+, which also reactivates oxaliplatin. The results also point toward a new direction in metal-catalyzed 
reactions, in which the catalyst activity can be enhanced by supplementing the system with co-catalyst metal.
Next, we incubated Pt compounds with PfuFt and human H-chain ferritin (FtH), which is another perspective 
drug  nanocarrier32. The samples were separated in native PAG and one gel was stained with 2 by the standard 
technique while the second gel was preincubated in 1 mM  CoCl2 in 50 mM HCl before staining. The HCl was 
included to prevent precipitation of Co(OH)2 in alkaline pH of the Tris-buffered gel.
The results shown in Fig. 8 clearly validate the improvement of sensitivity toward Pt compounds upon 
 Co2+-enhanced staining. The results also demonstrate the first practical use of the technique allowing identifica-
tion of the most appropriate nanocarrier for a specific compound. In this case, PfuFt is a superior carrier for the 
majority of Pt compounds with the exception of carboplatin that poorly interacts with both proteins. Previously, 
ferritins have been successfully used for cisplatin encapsulation. It was found that FtH is able to bind 5 molecules 
of cisplatin in each  chain33, while horse spleen apoferritin binds only 1 cisplatin  molecule34. From the results in 
Fig. 8, it is clear that PfuFt entraps a substantially larger quantity of therapeutic compound then FtH and might 
be therefore considered as a more effective carrier for nanomedical purposes.
Figure 7.  Restoration of catalytic activity of acrylamide-inhibited Pt compounds. Cisplatin (Cis), carboplatin 
(Carbo), and oxaliplatin (Oxa) were incubated with 0.1% acrylamide (Pt/AA) for 10 min. Then, competing 
metal was added and after 20 min incubation, the reaction mix containing 2 and BH was added. In order to 
exclude the probe activation by the competing metal, control samples without Pt compounds (yellow bars) 
were included. Fluorescence was measured after 60 min incubation. Results are the average of triplicate 
measurements (A). (B) The appearance of the 96-well plate under transilluminator. Mn = MnCl2, Fe = FeCl2, 
Co = CoCl2, Ni = Ni(OAc)2, Al = AlCl3, Zr = ZrOCl2,Ce = CeCl3, In = In(OAc)3.
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Conclusions
In conclusion, we have developed UV excitable blue fluorescent probes for the quantitative detection of ions 
and organometallic complexes of several transition metals. We demonstrate that the reaction in water with BH 
as a reducing agent provides superior results compared to conditions previously published. To the best of our 
knowledge, this is the first report, describing the methodology for the direct visualization of binding of Pd and 
Pt compounds to proteins or DNA. The catalytic activity of Pt compounds is suppressed by acrylamide, and 
potentially by other alkenes, but the inhibition can be reversed by  Co2+ or  Ni2+ treatment of the gel. Due to 
the growing interest in the development of new Pd and Pt anticancer compounds or possible applications of a 
Pd catalyst in bioorthogonal therapy, the identification of specific interactions with proteins, including serum 
transport proteins, is of crucial importance and the presented technique can greatly facilitate the task. The results 
of biochemical assays indicate that the technique can be further extended to the detection of protein and DNA 
complexes with organometallic compounds of Au, Rh, and Ru.
Materials and methods
Probe activation. The experiments were carried out in acrylic UV transparent 96-well plates (Corning, 
New York, NY, USA). Because the majority of the catalysts are dissolved in DMF, which dissolves the acrylic 
plates, 50 μL of 20% solvent was pipetted to the wells first. Then, 2 μL of a solution of 1 mM catalyst in DMF was 
added, and only then 150 μL of a master mix consisting of 20% solvent, Allyl- (1) 35 or PropUE (2) and reducing 
agents were added. The final concentrations were 25 μM for the probe, 10 μM for the catalyst, 5 mM for  NaBH4, 
and 10 mM for hydrazine, unless specified otherwise. The plate was incubated for 20–60 min at ambient tem-
perature. Fluorescence was measured with excitation at 365 nm and emission at 450 nm with various gains. All 
reactions were conducted in tri- or quadruplicates.
Detection of Pd complexes in PAG. After electrophoretic separation, the apparatus was disassembled 
and the gel placed into a dish with 10 mL of 200 µM probe in water. With gentle agitation, the probe was allowed 
to soak into the gel for at least 30 min. The gel was briefly rinsed with distilled water and placed onto the labo-
ratory UV transilluminator and excess of liquid was removed. Because some proteins have strong autofluores-
cence, a few images with different exposure times were collected to account for an autofluorescent signal. Then, 
2 mL of freshly prepared 10 mM  NaBH4 and used within 5 min from dissolving were poured to the surface of the 
gel and evenly spread with a plastic pipetting tip. The images at different exposure times were collected at various 
intervals within 5 or 6 min after the borohydride solution was applied. Sometimes, usually after 3 min, hydrogen 
bubbles started forming underneath the gel and had to be manually expelled to prevent interference with images 
acquisition. The procedure is similar to previously published detection of Pd nanoparticles in acrylamide  gels36.
Restoring catalytic activity of acrylamide-inhibited Pt compounds with metal ions. 2 μL of 
1 mM cisplatin, carboplatin and oxaliplatin with 50 μL of 0.1% acrylamide/bisacrylamide (37.5:1) were mixed in 
96-well plate and incubated for 10 min at ambient temperature. Then, 20 μL of 1 mM tested metal solutions were 
added. After 30 min incubation, PropUE and BH mix (130 μL) was added with final probe concentration 50 μM 
and BH 5 mM, and the fluorescence was measured after 1 h incubation at ambient temperature.
Figure 8.  Detection of Pt complexes with PfuFt (P) and human FtH (H) ferritins in native PAG without (a, 
b) and with  Co2+ treatment (c, d) with 2. Used compounds were: None,  K2PtCl4, cisplatin (Cis), carboplatin 
(Carbo), oxaliplatin (Oxa), Pt-phenanthroline (Phen), and Pt-quercetin (Quer). Gels were stained with 2 (a, c) 
followed by staining with Coomassie blue (b, d) to detect proteins in the same gel.
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Cobalt-enhanced detection of Pt compounds in PAG. The sample preparation and electrophoresis 
were carried out as described above. After electrophoresis, the gel was soaked for 30 min in 20 mL of 1 mM 
 CoCl2 in 50 mM HCl. The HCl was included to neutralized Tris pH 8.8 present in the native PA gel that would 
cause precipitation of insoluble Co(OH)2. The gel was briefly washed in water and soaked for 30 min in 100 μM 
solution of PropUE in 100 mM Tris.HCl pH 8.8. The Tris was included to restore slightly alkaline pH necessary 
for depropargylation reaction and for fluorescence activation of released UF.
Received: 12 November 2019; Accepted: 6 July 2020
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